Replies to post #65996 on Muscle Pharm Corporation (MSLPQ)

[learning curve]

Wouldn't their disclosure of when the record revenue in their filings mitigate any penalty in this regard?

They have disclosed among their largest sellers that revenue is recorded when product is shipped and payment is expected vs some other customers when product is shipped....it doesn't say how long until they expect to receive payment. I would assume they could drop millions in product at GNC around the world and as long as its shelf life provides time needed to liquidate product that this wouldn't constitute as "channel stuffing"?

Id be more worried about dilution from instantly vesting shares as well as new bonuses for the news execs taking new and higher positions?

15m + os is on the way

[bellator_exec]

While CEO Brad was saying the SEC Investigation was all wrapped up in a bow and signed off I posted this in April:

bellator_exec Monday, 04/14/14 01:11:23 PM
Re: deafelephant post# 65994
Post # of 72032
Thank you for your reply but as I stated previously; rumours are that the SEC investigation has now progressed beyond the previous disclosed matters. Please review my prior post if you mis-read my statement.

Currently there are rumours of ArthroCare type retail channel stuffing. Notice how MSLP has very recently begun to report revenues without the former return/rebate distinction?

I find these rumours to have merit as channel stuffing requires significant adjustments q over q and the return/rebate action is just one strategy to perpetuate fraud.

ArthroCare, who committed this fraud and which operated (and continues to this day) as a very successful business, did so to appear to be growing at a significantly greater rate than the company's actual performance.

Since then bb.com revenues from MSLP have fallen 21% and MSLP completely changed their financial reporting method to eliminate rebates and returns.